A Randomized Controlled Double-Blind Trial for Prevention of Recurrent Ischemic Priapism in Men With Sickle Cell Disease: A Pilot Study
Condition:   Priapism Due to Sickle Cell Disease Interventions:   Drug: Tadalafil;   Drug: Hydroxyurea;   Drug: Placebo Sponsor:   Vanderbilt University Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2021 Category: Research Source Type: clinical trials